Recent Posts

Advancing precision photothermal therapy byintegrating armored gold nanostars with real-timephotoacoustic thermometry and imaging

Author(s): Aidan J. Canning, Tri Vu1, Luca Menozzi, Paul Klippel, Xinrong Chen, Jianing Chen,Theresa Charity, Khang Hoang, Joseph J. Yang, Yun Jing, Gregory M. Palmer5,Junjie Yao1, Tuan Vo-Dinh

ABSTRACT

Nanoparticle-mediated photothermal therapy (PTT) is a promising strategy for cancer treatment; however,nanoparticle instability and lack of precise imaging tools for real-time temperature monitoring during therapyand nanoparticle tracking have hindered investigations in animal models. To address these critical issues, we pres-ent a theranostic platform that seamlessly integrates armored core–gold nanostar (AC-GNS)–mediated PTT withfull-view photoacoustic computed tomography (PACT), enabling nanoparticle tracking and real-time imaging-guided PTT in deep tissues. The AC-GNS platform delivered exceptional photostability and thermal resilience be-yond those of conventional nanoparticles while serving as a high-performance contrast agent for PACT and aphotothermal transducer for PTT. Integrating AC-GNS–mediated PTT with noninvasive PACT enabled whole-bodynanoparticle tracking, PTT treatment monitoring via thermal imaging, and thermal dose determination, culminat-ing in a 100% survival rate in a murine bladder cancer model without long-term treatment-related toxicity. Thistheranostic platform lays the foundation for broader research applications and provides opportunities for ad-vancing solid tumor treatment and response assessment research.

Click HERE to view publication

Investigating the Impact of Chronical Prenatal Alcohol Exposure on Fetal Vascular Development Across Pregnancy Stages Using Photoacoustic Tomography

Author(s): Hao Yang, Md Farhan Tanvir, Huabei Jiang

Graphical Abstract

This study investigates the effects of chronic prenatal alcohol exposure on fetal brain vascular development in mice using photoacoustic tomography. Key vascular parameters such as vessel diameter, density, and oxygen saturation were analyzed from embryonic Days 10 to 20. Results demonstrate significant vascular disruptions in alcohol-exposed groups compared to controls, highlighting the vulnerability of fetal development to alcohol exposure and the utility of photoacoustic tomography in detecting these changes.

ABSTRACT

Prenatal alcohol exposure (PAE) is a major contributor to fetal alcohol spectrum disorder (FASD), resulting in neurodevelopmental abnormalities. This study utilizes photoacoustic tomography (PAT) to investigate the effects of PAE on fetal brain vasculature in mice. PAT imaging was conducted from embryonic Day 10 (E10) to Day 20 (E20), aimed to compare two alcohol-exposed groups with a control group. Key vascular parameters, including blood vessel diameter and density, and oxygen saturation (sO2), were analyzed. Results show significant reductions in vessel size and density, as well as reduced sO2 levels, in alcohol-exposed groups, especially from E14 onward, compared to controls. These findings underscore the vulnerability of the fetal brain to alcohol exposure during early development and highlight the potential of PAT as a valuable tool for investigating FASD-related vascular changes.

Click HERE to view publication

A comparative study of plasmonic nanoparticles for targeted photothermal therapy of melanoma tumors using various irradiation modes

Author(s): Lidia Mikhailova, Elizaveta Vysotina, Maria Timofeeva, Elena Kopoleva, Van Gulinyan, Olesia Pashina, Konstantin Arabuli, Olga Gusliakova, Ekaterina Prikhozhdenko, Xiaoli Qi, Andrey Petrov, Eduard Ageev, Mihail Petrov, Constantino De Angelis, Mikhail Durymanov, Gleb Sukhorukov, Mikhail V. ZyuzinLidia Mikhailova, Elizaveta Vysotina, Maria Timofeeva, Elena Kopoleva, Van Gulinyan, Olesia Pashina, Konstantin Arabuli, Olga Gusliakova, Ekaterina Prikhozhdenko, Xiaoli Qi, Andrey Petrov, Eduard Ageev, Mihail Petrov, Constantino De Angelis, Mikhail Durymanov, Gleb Sukhorukov, Mikhail V. Zyuzin
ABSTRACT

Melanoma, a highly malignant and complex form of cancer, has increased in global incidence, with a growing number of new cases annually. Active targeting strategies, such as leveraging the α-melanocyte-stimulating hormone (αMSH) and its interaction with the melanocortin 1 receptor (MC1R) overexpressed in melanoma cells, enhance the concentration of therapeutic agents at tumor sites. For instance, targeted delivery of plasmonic light-sensitive agents and precise hyperthermia management provide an effective, minimally invasive treatment for tumors. In this work, we present a comparative study on targeted photothermal therapy (PTT) using plasmonic gold nanorods (Au NRs) as a robust and safe nanotool to reveal how key treatment parameters affect therapy outcomes. Using an animal model (B16-F10) of melanoma tumors, we compare the targeting abilities of Au NRs modified with two different MC1R agonists, either closely mimicking the αMSH sequence or providing a superior functionalization extent of Au NRs (4.5% (w/w) versus 1.8% (w/w)), revealing 1.6 times better intratumoral localization. Following theoretical and experimental assessments of the heating capabilities of the developed Au NRs under laser irradiation in either the femtosecond (FS)- or nanosecond (NS)- pulsed regime, we perform targeted PTT employing two types of peptide-modified Au NRs and compare therapeutic outcomes revealing the most appropriate PTT conditions. Our investigation reveals greater heat release from Au NRs under irradiation with FS laser, due to the relaxation rates of the electron and phonon temperatures dissipating in the surrounding, which correlates with a more pronounced 17.6 times inhibition of tumor growth when using FS-pulsed regime.

Click HERE to view publication

Rotational ultrasound and photoacoustic tomography of the human body

Author(s): Yang Zhang, Shuai Na, Jonathan J. Russin, Karteekeya Sastry, Li Lin, Junfu Zheng, Yilin Luo, Xin Tong, Yujin An, Peng Hu, Konstantin Maslov, Tze-Woei Tan, Charles Y. Liu, Lihong V. Wang

ABSTRACT

Imaging the human body’s morphological and angiographic information is essential for diagnosing, monitoring, and treating medical conditions. Ultrasonography performs the morphological assessment of the soft tissue based on acoustic impedance variations, whereas photoacoustic tomography (PAT) can visualize blood vessels based on intrinsic hemoglobin absorption. Three-dimensional (3D) panoramic imaging of the vasculature is generally not practical in conventional ultrasonography with limited field-of-view (FOV) probes, and PAT does not provide sufficient scattering-based soft tissue morphological contrast. Complementing each other, fast panoramic rotational ultrasound tomography (RUST) and PAT are integrated for hybrid rotational ultrasound and photoacoustic tomography (RUS-PAT), which obtains 3D ultrasound structural and PAT angiographic images of the human body quasi-simultaneously. The RUST functionality is achieved in a cost-effective manner using a single-element ultrasonic transducer for ultrasound transmission and rotating arc-shaped arrays for 3D panoramic detection. RUST is superior to conventional ultrasonography, which either has a limited FOV with a linear array or is high-cost with a hemispherical array that requires both transmission and receiving. By switching the acoustic source to a light source, the system is conveniently converted to PAT mode to acquire angiographic images in the same region. Using RUS-PAT, we have successfully imaged the human head, breast, hand, and foot with a 10 cm diameter FOV, submillimeter isotropic resolution, and 10 s imaging time for each modality. The 3D RUS-PAT is a powerful tool for high-speed, 3D, dual-contrast imaging of the human body with potential for rapid clinical translation.

Click HERE to view publication

3D protoacoustic radiography: A proof of principle study

Author(s): Prabodh K Pandey, Gilberto Gonzalez, Kristina Bjegovic, Leshan Sun, Yong Chen, Liangzhong Xiang

ABSTRACT

We propose protoacoustic radiography (PAR), an imaging modality combining proton excitation and acoustic detection for three-dimensional (3D) imaging from a single proton projection. PAR avoids the effect of multiple Coulomb scattering in imaging by detecting ultrasound. Proton-induced acoustic waves propagate spherically, enabling 3D imaging from a single projection. Additionally, the distinctive feature of proton beams—concentrating energy deposition primarily at the Bragg peak—allows for precise depth-selectivity through proton energy tuning. We performed PAR using clinical proton machines, and our results demonstrate the capability of PAR to reconstruct targets at various depths (between ∼20 and 23 cm) with an axial resolution of 1.3 mm by fully leveraging the Bragg peak and by tuning the kinetic energy of the proton beam. PAR offers opportunities for precise structural determination with protons both in biomedicine and nondestructive testing.

Click HERE to view publication

Ionizing radiation acoustic and ultrasound dual-modality imaging for visualization of dose on anatomical structures during radiotherapy

Author(s): Yaocai Huang, Ibrahim Oraiqat, Dale Litzenberg, Madhumithra Subramanian Karthikes, Christopher Tichacek, Glebys Gonzalez, Zhanpeng Xu, Sarah Dykstra, Borui Li, Scott Hadley, Eduardo G. Moros, Man Zhang, Paul L. Carson, Kyle C. Cuneo, Xueding Wang, Issam El Naqa, Wei Zhang
ABSTRACT

The aim of this study is to visualize the radiation dose on anatomical structures during radiation therapy (RT) by mapping radiation dose deposition and tracking anatomical structures simultaneously. A dual-modality volumetric imaging system, which combines ionizing radiation acoustic imaging (iRAI) and ultrasound (US) imaging, was developed to provide dose deposition and anatomical information in real-time during RT. The performance of the proposed system was first evaluated via experiments on tissue-mimicking phantoms driven by a custom motion stage. By using US imaging to correct the position of anatomical structures, the dose mapping accuracy of the system increased by up to 0.51 in structural similarity index measure (SSIM) and 74.60 % in Gamma passing rate (GPR) compared to standalone iRAI. A subsequent study on a rabbit model in vivo further confirmed the capability of the system in mapping of the radiation dose deposition in the target tissue as well as its change caused by the motion mainly due to the animal breath. These findings demonstrate that this first-of-its-kind dual-modality volumetric imaging system can provide volumetric dose-on-anatomy information during RT. After further validation in clinic, this technique holds potential for enhancing RT outcomes by ensuring accurate alignment between the planned radiation beams, the target, and surrounding organs at risk.

Click HERE to view publication

PHOTOSOUND TECHNOLOGIES, INC. ANNOUNCES PARNTERSHIP WITH VERASONICS

Partnership to Offer Vantage® Customers Expanded Capabilities in Applications Including Use with Photoacoustic Imaging, Thermoacoustic Imaging and Monitoring Radiation Therapy

Houston, TX, June 24, 2025 – PhotoSound® Technologies, Inc., today announced a partnership with Verasonics, Inc. the leader in research ultrasound to offer customers the PhotoSound Legion™ AMP for use with Vantage® and Vantage NXT Research Ultrasound Systems. Partnership will offer Vantage customers expanded capabilities by integrating the Legion AMP in applications using photoacoustic imaging, thermoacoustic imaging, and monitoring radiation therapy, among others.


The Legion AMP is a 128-channel receive signal preamplifier for use with Vantage or Vantage NXT Research Ultrasound Systems, in all channel configurations. It features high input impedance and a fixed 40db gain that amplifies weak signals especially in the lower frequency band with a high Signal to Noise Ratio (SNR). This is especially useful for research and development applications where a pulsed energy source is used where the excitation source is either weak or a long pulse.


“Adding a Legion AMP unit to a Vantage or Vantage NXT platform allows researchers to refine their receive capabilities, ensuring they are capturing key data,” said Jon K. Daigle, President and Chief Executive Officer at Verasonics. “This partnership will allow us to better serve our mutual customer base.”
“In thermo-, photo-, and optoacoustic imaging, lower frequency signals are often underrepresented because many systems don’t respond to them evenly. The Legion Amp maintains a consistent high SNR response across a broad frequency range, including below 100 kHz, which helps preserve the true shape and strength of the original signal,” said Peter Brecht CEO of PhotoSound Technologies. “I’m excited about this new collaboration and believe it will result in interesting new discoveries.”

Learn more, visit https://www.photosound.com/home/products/data-acquisition/legion-amp/

About Verasonics, Inc.

Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Washington, USA. Verasonics, the leader in research ultrasound, is focused on providing researchers and developers with the most advanced and flexible tools enabling them to develop new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries across North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance the art and science of ultrasound through their own research efforts.

Learn more by visiting the Verasonics website or following us on LinkedIn and X(Formerly Twitter).

Media Contact:

Verasonics, Inc. Toni Baumann
T: 425-242-7506
E: [email protected]

TriTom System Featured on Lithuanian National TV

We’re proud to share that PhotoSound Technologies’ TriTom™ system was recently featured on Lithuanian national television. The broadcast segment highlighted innovations in medical imaging, beginning with our laser partner EKSPLA (14:20), followed by the TriTom system (14:55), and continuing with other leaders in photoacoustic imaging, including PA Imaging (19:15) and iThera Medical (21:30).

Watch the full segment here

Topics covered include medical innovation, cancer detection, and advances in ultrasound and photoacoustic technologies.

4D IN VIVO DOSIMETRY FOR A FLASH ELECTRON BEAM USING RADIATION-INDUCED ACOUSTIC IMAGING

Authors: Kristina Bjegovic, Leshan Sun, Prabodh Pandey, Veljko Grilj, Paola Ballesteros-Zebadua, Ryan Paisley, Gilberto Gonzalez, Siqi Wang, Marie Catherine Vozenin, Charles L Limoli and Shawn (Liangzhong) Xiang

ABSTRACT

Objective. The primary goal of this research is to demonstrate the feasibility of radiation-induced acoustic imaging (RAI) as a volumetric dosimetry tool for ultra-high dose rate FLASH electron radiotherapy (FLASH-RT) in real time. This technology aims to improve patient outcomes by accurate measurements of in vivo dose delivery to target tumor volumes.

Approach. The study utilized the FLASH-capable eRT6 LINAC to deliver electron beams under various doses (1.2 Gy pulse−1 to 4.95 Gy pulse−1) and instantaneous dose rates (1.55 × 105 Gy s−1 to 2.75 × 106 Gy s−1), for imaging the beam in water and in a rabbit cadaver with RAI. A custom 256-element matrix ultrasound array was employed for real-time, volumetric (4D) imaging of individual pulses. This allowed for the exploration of dose linearity by varying the dose per pulse and analyzing the results through signal processing and image reconstruction in RAI.

Main Results. By varying the dose per pulse through changes in source-to-surface distance, a direct correlation was established between the peak-to-peak amplitudes of pressure waves captured by the RAI system and the radiochromic film dose measurements. This correlation demonstrated dose rate linearity, including in the FLASH regime, without any saturation even at an instantaneous dose rate up to 2.75 × 106 Gy s−1. Further, the use of the 2D matrix array enabled 4D tracking of FLASH electron beam dose distributions on animal tissue for the first time.

Significance. This research successfully shows that 4D in vivo dosimetry is feasible during FLASH-RT using a RAI system. It allows for precise spatial (∼mm) and temporal (25 frames s−1) monitoring of individual FLASH beamlets during delivery. This advancement is crucial for the clinical translation of FLASH-RT as enhancing the accuracy of dose delivery to the target volume the safety and efficacy of radiotherapeutic procedures will be improved.

Click HERE to view publication